Government panel moots clinical trial waiver for two cancer drugs
The two medicines - Aflibercept and Trastuzumab emtansine - are used in treatment of metastatic colorectal cancer and metastatic breast cancer respectively.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Breast Cancer | Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | Government | Herceptin | Pharmaceuticals